Browse diseases

…Background Over 40% of patients with inflammatory bowel disease (IBD) fail to respond to biologics, and no reliable biomarkers …

…ar null findings for obesity.Conclusions In this large national IBD inpatient cohort, obesity was not associated with increased rCD…

…posure, achieves near-complete histological resolution in a rat IBD model, with efficacy superior to standard therapies. Its favora…

… bariatric surgery are infrequently used in obese patients with inflammatory bowel disease in North and East Devon in the United Kingdom (UK). Journal of …

…al decision-making. This triage-first model exceeds the minimum IBD Standards of Care.Abstract P263 Figure 1…

… with inflammatory bowel disease (IBD) are at increased risk of colorectal cancer (CRC). Effective IBD CRC surveillance pathways, including high …

…iated with female sex, older age, non-Asian ethnicity, no prior IBD surgery and symptoms of active disease. Obesity in adults was a…

… consistent test for tracking disease activity in patients with inflammatory bowel disease (IBD) is currently a major challenge. Currently used biomarkers…

…Objective The incidence rate of inflammatory bowel disease (IBD) in England is 37/100 000 patient years. There is limited …

…t Molecular Inflammation Score (mMIS). Moreover, specific mouse IBD models have distinct signatures for B-cell, T-cell and enteric …

…). Azathioprine dosing and metabolite measurement in paediatric inflammatory bowel disease—does one size fit all? Journal of Crohns & Colitis 2018;12:S454…

…ith coeliac disease (CeD), inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). We present the first study comparing the prevalence of E…